Share this story
Dr Keith Bonham was awarded a Saskatchewan Cancer Agency grant
This 2-year grant is titled: ‘Preclinical evaluation of HDAC inhibitors in combination therapy.’
This 2-year grant is titled: ‘Preclinical evaluation of HDAC inhibitors in combination therapy.’